Blog
RSS FeedPosted by Michael Wonder on 28 Feb 2019
Drug prices aren’t a big problem, but Ottawa’s trying to control the market anyway
28 February 2019 - New policies will reduce access to new medicines for patients and impose massive new costs on taxpayers. ...
Posted by Michael Wonder on 21 Feb 2019
Canada finds "insufficient evidence" that Janssen blocked biosimilar competition
21 February 2019 - Despite the fact that the investigation confirmed many of the allegations against Janssen, the bureau concluded that, ...
Posted by Michael Wonder on 20 Feb 2019
New drug landscape dominated by high cost medicines
19 February 2019 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilization Information System research initiative, ...
Posted by Michael Wonder on 09 Feb 2019
U.S. PhRMA's fight to prevent lower Canadian drug prices
9 February 2019 - Drug industry turns up heat against Canada's drug price reforms. ...
Posted by Michael Wonder on 07 Feb 2019
Facing crackdown in Canada, drug makers offered billions in price cuts
6 February 2019 - Delayed rules would change countries Canada compares its prices to, dropping U.S. ...
Posted by Michael Wonder on 24 Jan 2019
Ottawa’s push for lower drug costs may hurt patients, stunt innovation
24 January 2019 - The federal government’s plan to lower prescription drug prices could impede access and thus limit the ...
Posted by Michael Wonder on 23 Jan 2019
Trudeau spreads the big Pharmacare myth that scores of Canadians can’t afford medicine
23 January 2019 - Across every income group, people pay more for media entertainment than prescription medicine. ...
Posted by Michael Wonder on 23 Jan 2019
The strange world of Canadian drug pricing
22 January 2019 - Imagine yourself in some hip new coffee shop. All you want is your standard cup to ...
Posted by Michael Wonder on 18 Jan 2019
Canada’s drug pricing regulator brings rare allegation of excessive pricing against Horizon Pharma
17 January 2019 - Canada’s drug-pricing regulator is accusing an Irish pharmaceutical company of charging an excessive price for a ...
Posted by Michael Wonder on 15 Nov 2018
Lowering the price of new drugs comes with too high a cost — Canadians' health
14 November 2018 - Ottawa wants to apply new price regulations, which will only cut manufacturer profits and deter the introduction ...
Posted by Michael Wonder on 29 Aug 2018
B.C. to sue opioid makers for health care expenses of overdose crisis
29 August 2018 - The British Columbia Government will sue opioid manufacturers including Purdue Pharma in an effort to recoup ...
Posted by Michael Wonder on 28 Aug 2018
Ottawa’s drug-pricing changes threaten Canadians who suffer from rare diseases
28 August 2018 - The federal government’s plan to increasingly regulate the costs of pharmaceuticals could mean Canadians with cystic ...
Posted by Michael Wonder on 24 Jul 2018
Debunking the myths about a Canadian pharmacare program
24 July 2018 - A national pharmacare program may one day be a reality in Canada. Myths abound about how it ...
Posted by Michael Wonder on 23 Jul 2018
Proposed PMPRB changes could limit Canada’s access to new drugs
20 July 2018 - While the federal government’s proposed amendments to Canada’s patented medicines regulations are aimed at reducing the ...
Posted by Michael Wonder on 17 Jun 2018
Drug patents could be Canada's special weapon in U.S. trade dispute
16 June 2018 - Taking an 'asymmetrical' approach and targeting U.S. intellectual property has worked in the past, experts say. ...